Radiology
Kang, Tae Wook
95 AppointmentRadiology, Liver cancer Center
Clinical Assistant Professor, Department of Radiology, Liver cancer Center, Sungkyunkwan University School of Medicine, Samsung Medical Center
Speciality Interests
Schedule
05 | FRI 02 |
MON 05 |
TUE 06 |
WEN 07 |
THU 08 |
---|---|---|---|---|---|
AM | |||||
PM |
Medical School
Sungkyunkwan University College of Medicine
Specialty Training
Fellowship | Department of Radiology, Sansung Medical Center | |
---|---|---|
Residency | Department of Radiology, Sansung Medical Center | |
Internship | Sansung Medical Center |
Participation in Academic Societies
and Research
Member, Korean Society of Radiology
Member, Korean Society of Ultrasound in Medicine
Member, Korean Society of Image-guided tumor ablation
Member, Korean Society of Abdominal radiology
Member, Korean Society of Interventional radiology
Thesis
EUR RADIOL 2021 10.1007/s00330-021-07897-8
Assessment of factors affecting washout appearance of hepatocellular carcinoma on CT
ULTRASONOGRAPHY 2021 10.14366/usg.20059
The semi-erect position for better visualization of subphrenic hepatocellular carcinoma during ultrasonography examinations
ANN SURG 2021 10.1097/SLA.0000000000003268
Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation
EUR RADIOL 2021 10.1007/s00330-021-07769-1
Rim-arterial enhancing primary hepatic tumors with other targetoid appearance show early recurrence after radiofrequency ablation
SURG ENDOSC 2021 10.1007/s00464-021-08310-7
Laparoscopic radiofrequency ablation of subcapsular hepatocellular carcinomas: risk factors related to a technical failure
EUR J RADIOL 2021 10.1016/j.ejrad.2020.109474
Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor
RADIOLOGY 2021 10.1148/radiol.2020200885
Comparison of Super-Resolution US and Contrast Material-enhanced US in Detection of the Spoke Wheel Sign in Patients with Focal Nodular Hyperplasia
EUR RADIOL 2020 10.1007/s00330-020-07438-9
Vanishing washout of hepatocellular carcinoma according to the presence of hepatic steatosis diagnostic performance of CT and MRI
INT J HYPERTHER 2020 10.1080/02656736.2020.1849824
Comparison of procedure-related complications between percutaneous cryoablation and radiofrequency ablation for treating periductal hepatocellular carcinoma
ANN SURG TREAT RES 2020 10.4174/astr.2020.99.4.238
Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria
KOREAN J RADIOL 2020 10.3348/kjr.2019.0910
Effect of Perfluorobutane Microbubbles on Radiofrequency Ablation for Hepatocellular Carcinoma Suppression of Steam Popping and Its Clinical Implication
RADIOLOGY 2020 10.1148/radiol.2020192275
Radiologic-Pathologic Correlation of Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement at Gadoxetic Acid-enhanced MRI A Multicenter Study
CLIN GASTROENTEROL H 2020 10.1016/j.cgh.2019.12.010
Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography
APPL SCI-BASEL 2020 10.3390/app10134607
Treatment Selection for Early to Intermediate Hepatocellular Carcinoma
RADIOLOGY 2020 10.1148/radiol.2020190639
Use of Gadoxetic Acid enhanced Liver MRI and Morality in More than 30000 Patients with Hepatocellular Carcinoma: A Nationwide Analysis
EUR RADIOL 2020 10.1007/s00330-019-06575-0
Updated 10-year outcomes of percutaneous radiofrequency ablation as first-line therapy for single hepatocellular carcinoma < 3 cm: emphasis on association of local tumor progression and overall survival
EUR RADIOL 2020 10.1007/s00330-020-06753-5
Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS
CARDIOVASC INTER RAD 2020 10.1007/s00270-019-02394-4
RF Ablation Versus Cryoablation for Small Perivascular Hepatocellular Carcinoma: Propensity Score Analyses of Mid-Term Outcomes
EUR RADIOL 2020 10.1007/s00330-019-06407-1
Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network
BRIT J RADIOL 2020 10.1259/bjr.20190719
Small masses (<= 3 cm) diagnosed as hepatocellular carcinoma on pre-treatment imaging: comparison of therapeutic outcomes between hepatic resection and radiofrequency ablation
EUR RADIOL 2019 10.1007/s00330-018-5993-y
Whole tumor ablation of locally recurred hepatocellular carcinoma including retained iodized oil after transarterial chemoembolization improves progression-free survival
Abdom Radiol (NY) 2019 10.1007/s00261-019-01968-7
Diagnosis of recurrent HCC: intraindividual comparison of gadoxetic acid MRI and extracellular contrast-enhanced MRI
EUR RADIOL 2019 10.1007/s00330-018-5868-2
Radiofrequency ablation for subcardiac hepatocellular carcinoma: therapeutic outcomes and risk factors for technical failure
CLIN RADIOL 2019 10.1016/j.crad.2019.01.019
Questionable correlation of the apparent diffusion coefficient with the histological grade and microvascular invasion in small hepatocellular carcinoma
ACTA RADIOL 2019 10.1177/0284185119842830
Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension
Abdom Radiol (NY) 2019 10.1007/s00261-018-1814-7
Differences in early imaging features and pattern of progression on CT between intrahepatic biliary metastasis of colorectal origin and intrahepatic non-mass-forming cholangiocarcinoma in patients with extrabiliary malignancy
WORLD J GASTROINTEST ONCOL 2019 10.4251/wjgo.v11.i3.227
Hepatic resection vs percutaneous radiofrequency ablation of hepatocellular carcinoma abutting right diaphragm
RADIOLOGY 2019 10.1118/radiol.2018181485
Intrahepatic Mass-formimg Cholangiocarcinoma: Arterial Enhancement Patterns at MRI and Prognosis
EUR RADIOL 2019 10.1007/s00330-018-5617-6
Percutaneous cryoablation for perivascular hepatocellular carcinoma: Therapeutic efficacy and vascular complications
KOREAN J RADIOL 2019 10.3348/kjr.2018.0339
Identification of Arterial Hyperenhancement in CT and MRI in Patients with Hepatocellular Carcinoma: Value of Unenhanced Images
KOREAN J RADIOL 2019 10.3348/kjr.2018.0320
Usefulness of Virtual Expiratory CT Images to Compensate for Respiratory Liver Motion in Ultrasound/CT Image Fusion: A Prospective Study in Patients with Focal Hepatic Lesions
EUR RADIOL 2019 10.1007/s00330-018-5602-0
Apparent diffusion coefficient as a potential marker for tumour differentiation, staging and long-term clinical outcomes in gallbladder cancer
EUR RADIOL 2019 10.1007/s00330-018-5657-y
LI-RADS v2017 categorisation of HCC using CT: Does moderate to severe fatty liver affect accuracy?
PLoS One 2019 10.1371/journal.pone.0210730
Multidisciplinary approach is associated with improved survival of hepatocellular carcinoma patients
Abdom Radiol (NY) 2018 10.1007/s00261-018-1653-6
Hepatic neuroendocrine tumors: gadoxetic acid-enhanced magnetic resonance imaging findings with an emphasis on differentiation between primary and secondary tumors
WORLD J GASTROENTERO 2018 10.3748/wjg.v24.i47.5331
Percutaneous ablation for perivascular hepatocellular carcinoma: Refining the current status based on emerging evidence and future perspectives
HEPATOLOGY 2018 10.1002/hep.30122
Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System
BRIT J RADIOL 2018 10.1259/bjr.20180177
Detection of recurrent hepatocellular carcinoma after surgical resection: Non-contrast liver MR imaging with diffusion-weighted imaging versus gadoxetic acid-enhanced MR imaging
J HEPATOL 2018 10.1016/j.jhep.2018.05.032
Reply to: "Influence of ablation technique on treatment failure for perivascular hepatocellular carcinoma''
RADIOLOGY 2018 10.1148/radiol.2018172743
Percutaneous US/MRI Fusion-guided Radiofrequency Ablation for Recurrent Subcentimeter Hepatocellular Carcinoma: Technical Feasibility and Therapeutic Outcomes
EUR RADIOL 2018 10.1007/s00330-018-5307-4
Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: Multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging
J HEPATOL 2018 10.1016/j.jhep.2018.02.026
Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes
CLIN RADIOL 2018 10.1016/j.crad.2018.02.007
Radiofrequency ablation versus surgical resection for multiple HCCs meeting the Milan criteria: propensity score analyses of 10-year therapeutic outcomes
EUR RADIOL 2018 10.1007/s00330-017-5248-3
Hepatic neuroendocrine tumour: Apparent diffusion coefficient as a potential marker of prognosis associated with tumour grade and overall survival
EUR RADIOL 2018 10.1007/s00330-017-5196-y
Added value of ancillary imaging features for differentiating scirrhous hepatocellular carcinoma from intrahepatic cholangiocarcinoma on gadoxetic acid-enhanced MR imaging
CAN J GASTROENTEROL HEPATOL 2018 10.1155/2018/7926923
Percutaneous Radiofrequency Ablation of Small (1-2 cm) Hepatocellular Carcinomas Inconspicuous on B-Mode Ultrasonographic Imaging: Usefulness of Combined Fusion Imaging with MRI and Contrast-Enhanced Ultrasonography
J HEPATOL 2018 10.1016/j.jhep.2018.01.024
Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma
CLIN RADIOL 2018 10.1016/j.crad.2018.01.016
Prediction and clinical implications of portal vein/superior mesenteric vein invasion in patients with resected pancreatic head cancer: the significance of preoperative CT parameters
BRIT J RADIOL 2018 10.1259/bjr.20170585
A radiofrequency device for tract ablation after liver biopsy: a single-institution human feasibility study
CLIN RADIOL 2018 10.1016/j.crad.2017.11.001
Integration of different criteria for borderline resectable pancreatic cancer using classification tree analysis: the use of radiological tumour-vascular interface in correlation with surgical and pathological outcomes
CLIN RADIOL 2018 10.1016/j.crad.2017.07.020
Initial radiofrequency ablation failure for hepatocellular carcinoma: repeated radiofrequency ablation versus transarterial chemoembolisation
RADIOLOGY 2018 10.1148/radiol.2017162452
Clinical Outcomes of Radiofrequency Ablation for Early Hypovascular HCC: A Multicenter Retrospective Study
CLIN IMAG 2018 10.1016/j.clinimag.2017.08.004
The qualitative and quantitative image analysis of MR imaging in patients with acute-on-chronic liver failure
CARDIOVASC INTER RAD 2017 10.1007/s00270-017-1751-9
Ultrasound-Guided Radiofrequency Ablation Using a New Electrode with an Electromagnetic Position Sensor for Hepatic Tumors Difficult to Place an Electrode: A Preliminary Clinical Study
BMC CANCER 2017 10.1186/s12885-017-3819-y
Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol
ACTA RADIOL 2017 10.1177/0284185117693459
Automatic image fusion of real-time ultrasound with computed tomography images: a prospective comparison between two auto-registration methods
DIGEST DIS SCI 2017 10.1007/s10620-017-4775-8
Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation
ACTA RADIOL 2017 10.1177/0284185116685921
Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata'' of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness
EUR J RADIOL 2017 10.1016/j.ejard.2017.036
Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma
EUR RADIOL 2017 10.1007/s00330-017-4804-1
Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging
CARDIOVASC INTER RAD 2017 10.1007/s00270-017-1666-5
Comparison Between CT and MR Images as More Favorable Reference Data Sets for Fusion Imaging-Guided Radiofrequency Ablation or Biopsy of Hepatic Lesions: A Prospective Study with Focus on Patient's Respiration
ULTRASOUND MED BIOL 2017 10.1016/j.ultrasmedbio.2017.01.027
IMAGE FUSION OF REAL-TIME ULTRASONOGRAPHY WITH COMPUTED TOMOGRAPHY: FACTORS AFFECTING THE REGISTRATION ERROR AND MOTION OF FOCAL HEPATIC LESIONS
EUR RADIOL 2017 10.1007/s00330-016-4662-2
Gadoxetic acid-enhanced magnetic resonance imaging characteristics of hepatocellular carcinoma occurring in liver transplants
ACTA RADIOL 2017 10.1177/0284185116673122
Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging
Korean J Radiol. 2017 May-Jun;18(3):427-443. doi: 10.3348/kjr.2017.18.3.427. Epub 2017 Apr 3.
Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal. Radiology
Eur Radiol. 2017 Apr;27(4):1722-1732. doi: 10.1007/s00330-016-4522-0. Epub 2016 Aug 10.
Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping
Cardiovasc Intervent Radiol. 2017 Mar;40(3):401-409. doi: 10.1007/s00270-016-1525-9. Epub 2016 Dec 8.
Radiofrequency Ablation of Hepatocellular Carcinoma with a "Nodule-in-Nodule" Appearance: Long-Term Follow-up and Clinical Implications
Br J Radiol. 2017 Mar;90(1071):20160361. doi: 10.1259/bjr.20160361. Epub 2017 Jan 31.
Chronological changes of radiofrequency ablation zone in rabbit liver: an in vivo correlation between gross pathology and histopathology
CLINICAL RADIOLOGY, FEB 2017, 72(2):141-149, DOI: 10.1016/j.crad.2016.09.008
Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma
Korean J Radiol. 2017 Jan-Feb;18(1):152-161. doi: 10.3348/kjr.2017.18.1.152. Epub 2017 Jan 5.
Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance
Korean J Radiol. 2017 Jan-Feb;18(1):173-179. doi: 10.3348/kjr.2017.18.1.173. Epub 2017 Jan 5.
New Radiofrequency Device to Reduce Bleeding after Core Needle Biopsy: Experimental Study in a Porcine Liver Model
Clin Radiol. 2016 Apr;71(4):402.e9-402.e15. doi: 10.1016/j.crad.2016.01.004. Epub 2016 Feb 10.
Tumefactive gallbladder sludge: the MRI findings
Liver Int. 2016 Apr;36(4):580-7. doi: 10.1111/liv.12991. Epub 2015 Nov 18.
Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma
Eur J Radiol. 2016 Mar;85(3):680-7. doi: 10.1016/j.ejrad.2015.12.029. Epub 2016 Jan 4.
Pancreatic neuroendocrine tumour: Correlation of apparent diffusion coefficient or WHO classification with recurrence-free survival
AJR Am J Roentgenol. 2016 Feb;206(2):291-300. doi: 10.2214/AJR.15.14974.
Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings
AJR Am J Roentgenol. 2016 Nov;207(5):1122-1127. Epub 2016 Aug 30.
Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma After Combined Transarterial Chemoembolization and Radiofrequency Ablation
Radiology. 2016 Oct;281(1):119-28. doi: 10.1148/radiol.2016151781. Epub 2016 Apr 26.
Mass-forming Intrahepatic Cholangiocarcinoma: Diffusion-weighted Imaging as a Preoperative Prognostic Marker
Eur Radiol. 2016 Oct;26(10):3437-46. doi: 10.1007/s00330-015-4190-5. Epub 2016 Jan 8.
Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma
Eur Radiol. 2016 Sep;26(9):3102-11. doi: 10.1007/s00330-015-4136-y. Epub 2015 Dec 3.
Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis
Liver Int. 2016 Aug;36(8):1187-95. doi: 10.1111/liv.13081. Epub 2016 Mar 15.
Effect of parenchymal uptake of perfluorobutane microbubbles (Sonazoid((R))) on radiofrequency ablation of the liver: in vivo experimental study
Radiology. 2016 Jul;280(1):300-12. doi: 10.1148/radiol.2016151243. Epub 2016 Jan 29.
Long-term Therapeutic Outcomes of Radiofrequency Ablation for Subcapsular versus Nonsubcapsular Hepatocellular Carcinoma: A Propensity Score Matched Study
Oncotarget. 2016 Jul 26;7(30):47794-47807. doi: 10.18632/oncotarget.10026.
Effect of oral antiviral treatment on long-term outcomes of radiofrequency ablation therapy for hepatitis B virus-related hepatocellular carcinoma
Br J Radiol. 2016 Jul;89(1063):20160054. doi: 10.1259/bjr.20160054. Epub 2016 May 10.
The value of contrast-enhanced dynamic and diffusion-weighted MR imaging for distinguishing benign and malignant splenic masses
J Vasc Interv Radiol. 2016 Jun;27(6):846-51. doi: 10.1016/j.jvir.2016.01.148. Epub 2016 Apr 11.
Safety of Percutaneous Biopsy for Hepatic Angiosarcoma: Results of a Multicenter Korean Survey
RADIOLOGY,SEP 2015,276(3):933-933
Aggressive Intrasegmental Recurrence of Periportal Hepatocellular Carcinoma after Radiofrequency Ablation: Role of Ablative Technique and Heat-Sink Effect Response
Invest Radiol. 2015 Feb;50(2):81-7. doi: 10.1097/RLI.0000000000000103.
A Novel Electrode With Electromagnetic Tip Tracking in Ultrasonography-Guided Radiofrequency Ablation A Phantom, Ex Vivo, and In Vivo Experimental Study
Eur J Radiol. 2015 Nov;84(11):2089-96. doi: 10.1016/j.ejrad.2015.08.007. Epub 2015 Aug 20.
Differentiation between pancreatic metastases from renal cell carcinoma and hypervascular neuroendocrine tumour: Use of relative percentage washout value and its clinical implication
Korean J Radiol. 2015 Nov-Dec;16(6):1253-6. doi: 10.3348/kjr.2015.16.6.1253. Epub 2015 Oct 26.
Pancreatic Candidiasis That Mimics a Malignant Pancreatic Cystic Tumor on Magnetic Resonance Imaging: A Case Report in an Immunocompetent Patient
Eur J Radiol. 2015 Jan;84(1):33-40. doi: 10.1016/j.ejrad.2014.10.020. Epub 2014 Nov 8.
Gastrointestinal stromal tumours: Correlation of modified NIH risk stratification with diffusion-weighted MR imaging as an imaging biomarker
Radiology. 2015 Jul;276(1):274-85. doi: 10.1148/radiol.15141215. Epub 2015 Feb 25.
Aggressive Intrasegmental Recurrence of Hepatocellular Carcinoma after Radiofrequency Ablation: Risk Factors and Clinical Significance
Radiology. 2015 Jun;275(3):908-19. doi: 10.1148/radiol.15141483. Epub 2015 Feb 16.
Small Hepatocellular Carcinoma: Radiofrequency Ablation versus Nonanatomic Resection-Propensity Score Analyses of Long-term Outcomes
Br J Radiol. 2015 Jun;88(1050):20140497. doi: 10.1259/bjr.20140497. Epub 2015 Apr 17.
Hepatic radiofrequency ablation: in vivo and ex vivo comparisons of 15-gauge (G) and 17-G internally cooled electrodes
Clin Radiol. 2015 Apr;70(4):387-94. doi: 10.1016/j.crad.2014.12.003. Epub 2015 Jan 9.
Percutaneous ultrasonography-guided radiofrequency ablation of hepatocellular carcinomas: usefulness of image fusion with three-dimensional ultrasonography
Eur J Radiol. 2015 Apr;84(4):555-62. doi: 10.1016/j.ejrad.2014.12.023. Epub 2015 Jan 7.
Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease
CLINICAL RADIOLOGY, MAY 2014, 69(5): 509-518, 10.1016/j.crad.2013.12.018
Inflammatory myofibroblastic tumours of the liver: Gadoxetic acid-enhanced and diffusion-weighted MRI findings with F-18-FDG PET/CT and clinical significance of regression on follow-up
Br J Radiol. 2014 Apr;87(1036):20130534. doi: 10.1259/bjr.20130534.
Comparison of therapeutic efficacy and safety of radiofrequency ablation of hepatocellular carcinomas between internally cooled 15-G and 17-G single electrodes
World J Gastroenterol. 2014 Apr 14;20(14):4059-65. doi: 10.3748/wjg.v20.i14.4059.
Single hepatocellular carcinoma <= 3 cm in left lateral segment: Liver resection or radiofrequency ablation
Radiology. 2014 Mar;270(3):888-99. doi: 10.1148/radiol.13130753. Epub 2013 Nov 22.
Perivascular versus Nonperivascular Small HCC Treated with Percutaneous RF Ablation: Retrospective Comparison of Long-term Therapeutic Outcomes
J Vasc Interv Radiol. 2014 Feb;25(2):307-14. doi: 10.1016/j.jvir.2013.10.025. Epub 2013 Dec 5.
Mistargeting after Fusion Imaging-Guided Percutaneous Radiofrequency Ablation of Hepatocellular Carcinomas
Clin Radiol. 2014 Dec;69(12):1249-58. doi: 10.1016/j.crad.2014.07.012. Epub 2014 Aug 20.
radiofrequency ablation of hepatic tumours: Factors affecting technical failure of artificial ascites formation using an angiosheath
AJR Am J Roentgenol. 2014 Nov;203(5):992-1000. doi: 10.2214/AJR.13.11980.
Value of Diffusion-Weighted MRI for Differentiating Malignant From Benign Intraductal Papillary Mucinous Neoplasms of the Pancreas
AJR Am J Roentgenol. 2014 Oct;203(4):803-12. doi: 10.2214/AJR.13.11914.
Differentiation of Malignant From Benign Focal Splenic Lesions: Added Value of Diffusion-Weighted MRI
Korean J Radiol. 2014 Jan-Feb;15(1):95-107. doi: 10.3348/kjr.2014.15.1.95. Epub 2014 Jan 8.
Terminology and Reporting Criteria for Radiofrequency Ablation of Tumors in the Scientific Literature: Systematic Review of Compliance with Reporting Standards